Peloton Wealth Strategists’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Peloton Wealth Strategists's NVS Position: Q3 2018 in Review
Peloton Wealth Strategists sold out of Novartis (NVS) in Q3 2018, closing a stake of 13,336 shares — an estimated $903K sold.
Peloton Wealth Strategists first reported a position in NVS in Q2 2013 and held it in 20 quarters. The position peaked at $3.45M in Q1 2015. 1,028 funds tracked by Wall St. Rank hold NVS as of Q3 2018.
- Peloton Wealth Strategists reported no remaining Novartis position as of Q3 2018 after selling out during the quarter.
- Peloton Wealth Strategists sold 13,336 Novartis shares in Q3 2018, an estimated $903K.
- Peloton Wealth Strategists first reported a position in Novartis in Q2 2013 and held it in 20 quarters.
- Peloton Wealth Strategists's Novartis position peaked at $3.45M in Q1 2015.
- 1,028 funds tracked by Wall St. Rank held Novartis as of Q3 2018.
Based on Peloton Wealth Strategists's 13F filing for Q3 2018, filed 14 Nov 2018.